PolyMedix, Inc.’s (PYMX) PMX-30063 Top-Class Defensin-Mimetic Antibiotic Displays Promising Activity Against Drug-Resistant Bacteria
PolyMedix, Inc., a biotechnology company focused on developing innovative therapeutic drugs to treat serious acute-care conditions, today announced that PMX-30063,…